Milla Pharmaceuticals Inc., a subsidiary of the Alter Pharma Group, announced that it has received FDA approval for its generic version of Precedex,...
Benzinga 2023-06-09 17:09:00 • 1 min
Capstone Companies, Inc. CAPC ("Capstone" or the "Company"), a designer, manufacturer and marketer of consumer inspired products that simplify daily living...
Benzinga 2023-06-09 15:57:00 • 1 min
WASHINGTON (AP) Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimers drug, a key step toward opening insurance...
U.S. News & World Report 2023-06-09 19:53:01 • 2 mins
Title of course: From Magic Mushrooms to Big Pharma What prompted the idea for the course? Im from the foothills of the Appalachians in southern Ohio, where...
The Conversation US 2023-06-09 12:29:31 • 1 min
AstraZeneca plc AZN has entered into a collaboration, exclusive option, and license agreement with Quell Therapeutics to develop multiple engineered...
Benzinga 2023-06-09 12:14:54 • 1 min
In this free webinar, learn how to accelerate clinical trials by addressing the challenges of sample collection and sample accuracy. Attendees will learn...
Benzinga 2023-06-08 12:30:00 • 2 mins
(RTTNews) - A panel of independent advisors convened by the Food and Drug Administration is currently meeting to determine whether Leqembi, an Alzheimer's...
Nasdaq 2023-06-09 19:05:25 • 1 min
Pharma giant AstraZeneca has signed a huge deal with a UK start-up to create treatments for diabetes and other autoimmune diseases. The FTSE 100 firm will...
Daily Mail 2023-06-09 20:50:08 • 1 min
IPH6501 is a first-in-class tetra-specific antibody-based natural killer cell engager therapeutic, based on ANKET platform, targeting CD20 developed for the...
Benzinga 2023-06-10 05:00:00 • 2 mins
Colgate-Palmolive said on June 8, 2023 that its board of directors declared a regular quarterly dividend of $0.48 per share ($1.92 annualized). Previously,...
The COMMODORE 2 study demonstrated that subcutaneous crovalimab every four weeks was non-inferior to intravenous eculizumab every two weeks, with comparable...
Benzinga 2023-06-09 12:45:00 • 1 min
Human Trial with Novel Glaucoma Treatment Rendered a Clinically Meaningful Efficacy Outcome and Positive Safety and Tolerability Data Today, MediPrint...
Benzinga 2023-06-09 00:11:00 • 2 mins
VEVYE is the first and only cyclosporine solution indicated for the treatment of signs and symptoms of dry eye disease with efficacy demonstrated after 4...
Benzinga 2023-06-08 13:23:00 • 2 mins
Fintel reports that on June 9, 2023, Stifel upgraded their outlook for Repare Therapeutics ( NASDAQ:RPTX ) from Hold to Buy. Analyst Price Forecast Suggests...
Health care stocks were mixed premarket Friday as the iShares Biotechnology ETF (IBB) was up 0.3% and the Health Care Select Sector SPDR Fund ( XLV ) was...
Below is Validea's guru fundamental report for TG THERAPEUTICS INC ( TGTX ). Of the 22 guru strategies we follow, TGTX rates highest using our Quantitative...
Nasdaq 2023-06-09 20:04:38 • 1 min
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for...
Two women who accidentally sealed their eyes shut with superglue after mistaking the bottles for eye drops have shared their agonizing recoveries. Jennifer...
Daily Mail 2023-06-08 21:04:42 • 1 min
Below is Validea's guru fundamental report for KEURIG DR PEPPER INC ( KDP ). Of the 22 guru strategies we follow, KDP rates highest using our Multi-Factor...
Nasdaq 2023-06-09 16:05:29 • 1 min